{"id":"NCT00621517","sponsor":"East Tennessee State University","briefTitle":"Bupropion and Restless Legs Syndrome","officialTitle":"Bupropion and Restless Legs Syndrome","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2008-02","primaryCompletion":"2009-07","completion":"2009-07","firstPosted":"2008-02-22","resultsPosted":"2012-04-05","lastUpdate":"2019-03-06"},"enrollment":60,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Restless Legs Syndrome"],"interventions":[{"type":"DRUG","name":"Bupropion","otherNames":["Wellbutrin"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to determine if bupropion will improve the symptoms of restless legs syndrome (RLS).","primaryOutcome":{"measure":"Change in International Restless Legs Syndrome Study Group (IRLSSG) Severity Scale.","timeFrame":"Baseline, three weeks, and six weeks","effectByArm":[{"arm":"Bupropion","deltaMin":-10.4,"sd":10.1},{"arm":"Placebo","deltaMin":-7.6,"sd":7.1}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":2,"exclusionCount":9},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":29},"commonTop":["nausea"]}}